التفاصيل البيبلوغرافية
| العنوان: |
Ventricular assist devices in transposition and failing systemic right ventricle: role of tricuspid valve replacement. |
| المؤلفون: |
Gonzalez-Fernandez, Oscar1,2 (AUTHOR), Rita, Fabrizio De1,3 (AUTHOR), Coats, Louise1,3 (AUTHOR), Crossland, David1 (AUTHOR), Nassar, Mohamed S1 (AUTHOR), Hermuzi, Antony1,3 (AUTHOR), Lopes, Bruno Santos1 (AUTHOR), Woods, Andrew1 (AUTHOR), Robinson-Smith, Nicola1 (AUTHOR), Petit, Thibault1,4 (AUTHOR), Seller, Neil1 (AUTHOR), O'Sullivan, John1,5 (AUTHOR), McDiarmid, Adam1 (AUTHOR), Schueler, Stephan1 (AUTHOR), Hasan, Asif1 (AUTHOR), MacGowan, Guy1,5 (AUTHOR), Jansen, Katrijn1,3 (AUTHOR) katrijn.jansen1@nhs.net |
| المصدر: |
European Journal of Cardio-Thoracic Surgery. Sep2022, Vol. 62 Issue 3, p1-10. 10p. |
| مصطلحات موضوعية: |
*TRICUSPID valve, *HEART assist devices, *TRANSPOSITION of great vessels, *HEART transplantation |
| مستخلص: |
Open in new tab Download slide OBJECTIVES Ventricular assist device (VAD) for systemic right ventricular (RV) failure patients post-atrial switch, for transposition of the great arteries (TGA), and those with congenitally corrected TGA has proven useful to reduce transpulmonary gradient and bridge-to-transplantation. The purpose of this study is to describe our experience of VAD in systemic RV failure and our move towards concomitant tricuspid valve replacement (TVR). METHODS This is a single-centre retrospective study of consecutive adult patients receiving HeartWare VAD for systemic RV failure between 2010 and 2019. From 2017, concomitant TVR was performed routinely. Demographic, clinical variables and echocardiographic and haemodynamic measurements pre- and post-VAD implantation were recorded. Complications on support, heart transplantation and survival rates were described. RESULTS Eighteen patients underwent VAD implantation. Moderate or severe systemic tricuspid regurgitation was present in 83.3% of patients, and subpulmonic left ventricular impairment in 88.9%. One-year survival was 72.2%. VAD implantation was technically feasible and successful in all but one. Post-VAD, transpulmonary gradient fell from 16 (15–22) to 10 (7–13) mmHg (P = 0.01). Patients with TVR (n = 6) also demonstrated a reduction in mean pulmonary and wedge pressures. Furthermore, subpulmonic left ventricular end-diastolic dimension (44.3 vs 39.6 mm; P = 0.03) and function improved in this group. After 1 year of support, 72.2% of patients were suitable for transplantation. CONCLUSIONS VAD is an effective strategy as bridge-to-candidacy and bridge-to-transplantation in patients with end-stage systemic RV failure. Concomitant TVR at the time of implant is associated with better early haemodynamic and echocardiographic results post-VAD. [ABSTRACT FROM AUTHOR] |
| قاعدة البيانات: |
Academic Search Index |
Full Text Finder